Suvretta Capital Management, Llc - Dec 3, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Stock symbol
BNTC
Transactions as of
Dec 3, 2024
Transactions value $
$403,200
Form type
4
Date filed
12/5/2024, 04:36 PM
Previous filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $357K +37.2K +0.47% $9.60 7.96M Dec 3, 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $46.2K +4.81K +0.51% $9.60 955K Dec 3, 2024 See footnotes F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature